Stationary energy storage seeks to disrupt the electricity markets on a global scale. Safe, inexpensive energy storage, the missing link in the electricity grid’s 140-year history, will: (1) supplement large capital infrastructure upgrades with low-cost storage; (2) pair with renewables to realize cost effective alternatives to fossil fuel generation; (3) upturn legislative and regulatory restrictions, ushering in digital and energy-sharing economic and societal opportunities.
PolyJoule has developed a non-lithium form of energy storage that is built purposely for the electricity grid. Safety is molecularly designed into our battery chemistry, streamlining permitting and usability. PolyJoule batteries can respond to both base loads and peak loads in microseconds, allowing the same energy storage system to participate in multiple power markets and deployment use cases. Upfront asset costs are low. Lifetime battery reliability is high. This lecture will introduce PolyJoule, our proprietary energy storage chemistry, its performance profile, and how congested electricity grids, renewable adaptation, and environmental tidal waves all benefit from low-cost, high-power energy storage assets.
Technology is changing the world at a blistering pace, and established industries are being rapidly displaced, often in a matter of years. Airbnb, Uber, Netflix, Spotify - all multi-billion dollar businesses which unseated highly entrenched incumbents. Nowhere is this more evident than the transportation sector, and the highly integrated and coordinated automotive industry.
The automotive industry is telling the world that it's reinventing itself too, but the supposedly groundbreaking new vehicles they offer are largely built on the same century-old vehicle designs. Global need for immediate order-of-magnitude improvements in vehicle efficiency combined with a rise in mobility-as-a-service preferences and autonomous systems mean the traditional incremental change in vehicle design will not be sufficient for auto makers to remain competitive.
Indigo Technologies is working to break this vehicle design paradigm. The vehicles of tomorrow need to be highly efficient, lightweight, modular, and flexible, using advanced manufacturing techniques and materials. Indigo unlocks this future with its core technology, an innovative in-wheel motor with integrated active suspension, which frees vehicle designers from the constraints of encapsulating a traditional powertrain and allows for efficient design. Marshall will explain how this technology, as well as Indigo's wireless power transfer system, is helping forward-thinking OEMs design and build the future of mobility.
The adherence to treatment in injectable therapies for chronic diseases (e.g. rheumatoid arthritis, multiple sclerosis, psoriasis, Crohn’s disease, etc.) is extremely low (45% - 60%) and in part due to the inconvenience and anxiety associated with using needles and syringes. Biological medicines treating those conditions cannot be formulated as pills and as such there is a huge opportunity for new technologies replacing needles and syringes to transform the perception, approachability and market penetration of such therapies. Portal has developed a next-generation needle-free drug delivery platform that is computer-controlled, easy to use and patient preferred. Real time injection tracking via cloud-based connectivity enables patients and their care teams to manage their condition better and take charge of their wellbeing. Issued from Professor Ian Hunter’s research at the MIT BioInstrumentation Lab, this technology leverages advances in multiple disciplines such as high-power density electromagnetic actuators, ARM-based micro-electronics and embedded software, and energy storage. The company is at the commercial stage, preparing to launch a drug/device combination product with Takeda Pharmaceuticals in the field of Inflammatory Bowel Diseases. A live demonstration of the Portal Device will be presented at the Symposium.